COVID-19 Treatment Clinics

These clinics have been launched to help our patients access outpatient therapies such as monoclonal antibody treatment when available.

The Inova Infusion Clinics are accepting referrals for patients from all Inova Emergency Rooms, Inova Urgent Care Centers, Inova Primary Care Offices, as well as community practices.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses. The monoclonal antibody treatments offered specifically target the spike protein. Remdesivir is an intravenous drug used to treat COVID-19.

Bebtelovimab is the monoclonal antibody treatment in current use at Inova. Some information about Bebtelovimab:

• It is approved for use by the FDA under the Emergency Use Authorization (EUA) for the treatment of mild to moderate symptoms of all three strains of Covid-19, including Delta, Omicron and Omicron subvariants BA 1.1, BA.2, in adults and children over 12 years, and weighing at least 88 pounds.
• It is given intravenously over at least 30 seconds via IV push.
• Patients will be required to remain under observation for one hour post infusion.

Bebtelovimab FDA Fact Sheet

NOTE: If the patient has been prescribed and can obtain oral COVID-19 treatment, the patient will not be considered eligible for infusion treatment.

Effective Jan. 31, 2022, we are expanding to Tier 4 inclusion criteria for all infusions. To qualify for consideration, patients need a positive COVID-19 test and must be within 7 days of illness onset and also meet at least one of the criteria below:

1. Moderate to severe Immunocompromised OR
2. One of the following:

• BMI > or = 25 (or > 85th percentile if < 18 years old).
• Age > or = 65
• Pregnancy
• Chronic kidney disease
• Diabetes
• Cardiovascular disease (including hypertension, atrial fibrillation, heart failure, valvular heart disease, pulmonary hypertension, or history of stroke)
• Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma, interstitial lung disease, cystic fibrosis and pulmonary hypertension)
• Sickle cell disease
• Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
• Having a medical-related technological dependence [for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID- 19)

As a result of a very high case load as well as significantly restricted supply, we are currently managing ALL requests online. We have also instituted restricted eligibility for treatment at our infusion centers and emergency rooms. Please submit all requests for treatment using the link(s) below. Note that you or your patient will ONLY receive a call to schedule a treatment if: 1) the patient meets the majority of criteria; and 2) we have supply available.

Providers:

Complete this form to refer a symptomatic patient or or via "Ambulatory Referral to Extended COVID-19 Care Clinic Assessment" via Epic for Inova providers.

Patients (symptomatic only):

To be referred, please contact your primary care provider. If you do not have a primary care provider, complete the online self-referral form. If you meet the revised criteria and we have the drug available, you will receive a call to be scheduled for your infusion treatment.

There have not been any studies on pregnant patients. Given the low risk associated with this medication, pregnant patients can receive the treatment if requested.

The cost of telemedicine visits and monoclonal antibodies infusion treatment for COVID-19 are covered by Medicare, Medicaid, and commercial insurance. Copays and deductibles may apply, and your out of pocket cost will vary depending on your insurance coverage. The infusion and telemedicine visits are available to the uninsured who can apply for financial assistance.

Inova is not charging for the monoclonal antibodies product to treat COVID-19, but will charge for administering the medication. Copays and deductibles may apply, and your out of pocket cost will vary depending on your insurance coverage.

Uninsured patients can apply for financial assistance. Financial assistance acceptance is dependent on meeting qualifications. For more information on requirements, please visit the webpage: Inova - Financial Assistance